Sabby Management, LLC Adamis Pharmaceuticals Corp Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.33 - $0.66 $29,109 - $58,218	-88,210 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.33 - $0.89 $29,109 - $78,506	88,210 New	88,210 $32,000
Q4 2019 Feb 14, 2020	SELL	$0.51 - $1.26 $93,513 - $231,032	-183,359 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$0.7 - $1.46 $128,351 - $267,704	183,359 New	183,359 $129,000
Q4 2017 Feb 14, 2018	SELL	$3.5 - $5.65 $351,323 - $567,135	-100,378 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.5 - $5.65 $451,701 - $567,135	100,378	100,378 $524,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.